1 active not recruiting, 1 completed. 2 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Active not recruiting 1, Completed 1 |
| Phase 2 | 1 | Active not recruiting 1 |
Follow Fibroblast Growth Factor 2: new trials by email Literature Review of Fibroblast Growth Factor 2 trials Research Report on Fibroblast Growth Factor 2
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| In-office Repair of Chronic Tympanic Membrane Perforations Fibroblast Growth Factor 2, Saline control - Chronic Tympanic Membrane Perforation | Phase 1 / Phase 2 | Active not recruiting | D. Bradley Welling, MD, PhD | 20 | 2024-06-15 | 2026-06-24 |
| Evaluation the Pharmacokinetics,Safety,Tolerability of Single Intravitreal Injection RC28-E in Subjects With Wet Age-Related Macular Degeneration RC28-E - Neovascular Age-related Macular Degeneration | Phase 1 | Completed | RemeGen Co., Ltd. | 12 | 2019-01-07 | 2021-04-27 |
D. Bradley Welling, MD, PhD (1) · RemeGen Co., Ltd. (1)
China (1) · United States (1)
D Bradley Welling, MD, PhD (1)